NEWS

C'ENSIL developed by ATDS technology

최고관리자 0 3359

0d427a5c90b745ed68c4df4ac2a502aa_1553735075_0329.JPG



C'ENSIL is made by ATDS technology.

ATDS(Amphiphilic Transdermal Delivery System)


What  is ATDS technology?
Our patented ATDS technology (Amphiphilic Transdermal Delivery System),


developed by Sage Pharmaceuticals, Inc.in the USA,

allows formula to penetrate through both hydrophilic layers and lipophilic layers

by using special amphiphilic solvent.

(No irritation, Penetration UP, Stability UP)

Amphiphilic Solvent

Unlike most of other products that use water or alcohol as a solvent,

C'ENSIL dissolves vitamin C and various active ingredients into our special amphiphilic solvent

which is both hydrophilic and lipophilic.

Our skin is composed of hydrophilic layers and lipophilic layers.

Since Vitamin C is a water-soluble ingredients,

It cannot be absorbed in lipophilic layers.

However, through ATDS technology, vitamin C can actually penetrate deeply and evenly,

not only into hydrophilic layers but also lipophilic layers,

which can maximize the effect of vitamin C.​


, , , , , , , , , ,

  • CEO : 김수언 |
  • Address : 2F, 41, Hakdong-ro 3-gil, Gangnam-gu, Seoul, Republic of Korea |
  • E-mail : info@aespio.com|

  • Tel : 02-3442-2525|
  • Business registration number : 108-81-71905